Paraoxonase and arylesterase activities in the serum of two hyperlipoproteinaemic patients after repeated extracorporal lipid precipitation

Chemico-Biological Interactions

Volumn 119-120, Issue , 1999, Pages 405-411

  Reiner, Elsa ^a   Svedružić, Draženka ^a   Simeon Rudolf, Vera ^a   Lipovac, Vaskresenija ^b   Gavella, Mirjana ^b   Mrzljak, Vladimir ^b  

^a INSTITUTE FOR MEDICAL RESEARCH AND OCCUPATIONAL HEALTH   (Croatia)

^b University of Zagreb   (Croatia)

Author keywords

Heparin induced extracorporal lipid precipitation (HELP); Human serum arylesterase; Human serum paraoxonase; Hyperlipoproteinaemia

Indexed keywords

ARYLDIALKYLPHOSPHATASE; ARYLESTERASE; CHOLESTEROL; PARAOXON; PHENYLACETIC ACID; TRIACYLGLYCEROL;

ATHEROGENESIS; CASE REPORT; CONFERENCE PAPER; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME SPECIFICITY; HUMAN; HYDROLYSIS; HYPERLIPOPROTEINEMIA; LIPID BLOOD LEVEL; NON INSULIN DEPENDENT DIABETES MELLITUS;

ARYLDIALKYLPHOSPHATASE; CARBOXYLIC ESTER HYDROLASES; CHELATING AGENTS; DIABETES MELLITUS, TYPE 2; EDETIC ACID; ESTERASES; EXTRACORPOREAL CIRCULATION; HEPARIN; HUMANS; HYPERLIPOPROTEINEMIAS; LIPIDS; PARAOXON; PHENYLACETATES; PRECIPITATION; RENAL DIALYSIS; SUBSTRATE SPECIFICITY;

EID: 0344654710     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(99)00052-6     Document Type: Conference Paper

References (20)

1. Mackness M.I., Arrol S., Durrington P.N. Paraoxonase prevents accumulation of lipoperoxides in low density lipoprotein. FEBS Lett. 286:1991;152-154.
2. Mackness M.I., Arrol S., Durrington P.N. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis. 104:1993;129-135.
3. Watson A.D., Berliner J.A., Hama S.Y., La Du B.N., Faul K.F., Fogelman A.M., Navab M. Protective effect of HDL associated paraoxonase-inhibition of the biological activity of minimally oxidized low density lipoprotein. J. Clin. Invest. 96:1995;2882-2891.
4. Picard S. Lipoprotein glyco-oxidation. Diabetes Metab. 21:1995;89-94.
5. Seidel D., Wieland H. Ein neues Verfahren zur selektiven Messung und extrakorporalen Elimination von Low-Density-Lipoproteinen. J. Clin. Chem. Clin. Biochem. 20:1982;684-685.
6. Seidel D. The HELP system: an efficient and safe method of plasmatherapy in the treatment of severe hypercholesterolemia. Therapeutische Umschau. 47:1990;514-519.
7. Reiner E., Pavković E., Radić Z., Simeon-Rudolf V. Differentiation of esterases reacting with organophosphorus compounds. Chem.-Biol. Interact. 87:1993;77-83.
8. Sorenson R.C., Primo-Parmo S.L., Kuo C.L., Adkins S., Lockridge O., La Du B.N. Reconsideration of the catalytic center and mechanism of mammalian paraoxonase/arylesterase. Proc. Natl. Acad. Sci. USA. 92:1995;7187-7191.
9. Reiner E., Radić Z., Simeon-Rudolf V. Hydrolysis of paraoxon and phenylacetate by human serum esterases. Reiner E., Aldridge W.N., Hoskin F.C.G. Enzymes Hydrolysing Organophosphorus Compounds. 1989;30-40 Ellis Horwood, Chichester.
10. Cain K., Reiner E., Williams D.G. The identification and characterisation of two separate carboxyl esterases in guinea-pig serum. Biochem. J. 215:1983;91-99.
11. Kostner G.M., Molinari E., Pichler P. Evaluation of a new HDL2/HDL3 quantitation method based on precipitation with polyethylen glycol. Clin. Chim. Acta. 148:1985;139-147.
12. Nalto H.K. Reliability of lipid, lipoprotein and apolipoprotein measurements. Clin. Chem. 34:1988;B84-B94.
13. Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogen. Acta Haematol. 17:1957;237-240.
14. Cooper B.N. Statistic for Experimentalists. 1989;Pergamon, Oxford.
15. Sprent P. Applied Non-Parametric Statistical Methods. 1989;Chapman and Hall, London.
16. Reiner E., Pavković E., Simeon V., Sučić M., Lipovac V. Activities of serum esterases in patients with hyperlipidaemia. Croat. Chem. Acta. 69:1996;317-325.
17. Reiner E., Simeon-Rudolf V., Škrinjarić-Špoljar M. Catalytic properties and distribution profiles of paraoxonase and cholinesterase phenotypes in human sera. Toxicol. Lett. 82/83:1995;447-452.
18. Reiner E., Hodoba D., Pavković E., Pecotić Z., Gruić I., Čović-Peko I., Simeon-Rudolf V. Serum paraoxonase and cholinesterase activities in demented elderly patients. Period. Biol. 97:1996;301-304.
19. Geldmacher-von Mallinckrodt M., Diepgen T.L. The human serum paraoxonase-polymorphism and specificity. Toxicol. Environ. Chem. 18:1988;79-196.
20. Sogorb M.A., Monroy A., Vicedo J.L., Baril J., Vilanova E. Serum albumin can hydrolyse organophosphorus compounds by an intermediate phosphorylated mechanism. Where is the borderline dividing A and B-esterases? Third International Meeting on Esterases Reacting with Organophosphorus Compounds, Dubrovnik, Croatia, Programme and Abstracts. 1998;Institute for Medical Research and Occupational Health, Zagreb. Abstract No. P20.